Malaria -- Worldwide/Unknown
Background: Stalled progress in controlling _Plasmodium falciparum_ malaria highlights the need for an effective and deployable vaccine. RTS,S/AS01, the most effective malaria vaccine candidate to date, demonstrated 55.8% (97.5% confidence interval [CI], 51-60) efficacy over 12 months in African children.
Methods: We conducted a double-blind, randomised, controlled trial of a low-dose circumsporozoite protein-based vaccine, R21, with 2 different doses of adjuvant, Matrix-M(TM) (MM), in
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8326270&promed&0
No comments:
Post a Comment